12
Participants
Start Date
July 31, 2010
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
PF-04620110
"The five treatments are:~A) single dose of 5 mg immediate release tablets in the fasted state; B) single dose of 5 mg modified release osmotic capsule with a short duration of modified release 1 (MR1) in the fasted state; C) single dose of 5 mg modified release osmotic capsule with a long duration of modified release 2 (MR2) in the fasted state; D) single dose of 5 mg modified release osmotic capsule with a short duration of modified release 1 (MR1) in the fed state; E) single dose of 5 mg modified release osmotic capsule with a long duration of modified release 2 (MR2) in the fed state."
Pfizer Investigational Site, Singapore
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Pfizer
INDUSTRY